Topiramate 65841-0651-05
- Manufacturer
- Zydus Lifesciences Limited
- Dosage Form
- Capsule, Coated Pellets
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- October 14, 2009
- Listing Expires
- December 31, 2026
- Application
- ANDA078877
Need to source Topiramate? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Topiramate | 15 mg/1 |
Drug Class
Cytochrome P450 2C19 Inhibitors [MoA]Cytochrome P450 3A4 Inducers [MoA]Decreased Central Nervous System Disorganized Electrical Activity [PE]
Selected Package
65841-0651-05Selected500 CAPSULE, COATED PELLETS in 1 BOTTLE (65841-651-05)
Other packages for this product(4)
100 CAPSULE, COATED PELLETS in 1 BOTTLE (65841-651-01)
1000 CAPSULE, COATED PELLETS in 1 BOTTLE (65841-651-10)
60 CAPSULE, COATED PELLETS in 1 BOTTLE (65841-651-14)
90 CAPSULE, COATED PELLETS in 1 BOTTLE (65841-651-16)